Young-Adulthood Insulin Resistance Raises ASCVD Risk Later, Mediated Through Midlife Metabolic Syndrome
Young-adulthood insulin resistance (IR) was linked to a 1.50-fold higher risk of atherosclerotic cardiovascular disease (ASCVD) later in life. Midlife metabolic syndrome (MetS) mediated 63.4% of this association. The analysis included 3,622 Black and White participants in the US CARDIA study. They were aged 18–30 at baseline and free of […]
